Global Indemnity director equity grant increases stake to 74,542 shares

Rhea-AI Filing Summary

Global Indemnity Group, LLC (GBLI) reported a Form 4 showing that director Thomas McGeehan was granted 4,113 Class A Common Shares on 09/30/2025 in recognition of services as a board member. The shares were reported at a price of $28.87 per share. Following the grant, the reporting person beneficially owned 74,542 Class A Common Shares. The form was signed by an attorney-in-fact on 10/02/2025 and includes an explanation that the grant represents vested shares issued for board services.

Positive

• 4,113 vested Class A Common Shares granted to a director, explicitly for services rendered, indicating alignment of interests
• Post-grant beneficial ownership of 74,542 shares is disclosed, improving transparency

Negative

• None.

Insights

Corporate Governance Analyst

Director received vested equity as compensation, aligning interests with shareholders.

The filing shows a grant of 4,113 Class A Common Shares to Thomas McGeehan for board service, explicitly described as vested. Equity grants to directors are a routine governance practice to align board incentives with shareholders.

The transaction price is listed as $28.87 per share and the report states post-grant beneficial ownership of 74,542 shares, providing a clear picture of the director's current stake.

Insider Transactions Specialist

Form 4 discloses a non-derivative acquisition of common shares by a director on 09/30/2025.

The document is a straightforward Section 16 filing reporting an acquisition (code A) of 4,113 shares. The explanation section explicitly states the grant was in recognition of services as a board member.

No derivative instruments, dispositions, or other transactions are reported on this Form 4, and the filing was executed via attorney-in-fact on 10/02/2025.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

McGeehan Thomas

(Last) (First) (Middle)

112 S. FRENCH STREET, SUITE 105

(Street)

WILMINGTON DE 19801

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Global Indemnity Group, LLC [ GBLI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/30/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Shares	09/30/2025		A		4,113(1)	A	$28.87	74,542	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents a grant of vested Class A Common Shares ("A Common Shares") in recognition of services rendered as a board member of the Issuer.

Remarks:

Exhibit 24 - Power of Attorney

	/s/Nathaniel D. DeRose, Attorney-in-fact	10/02/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did GBLI director Thomas McGeehan report on Form 4?

He was granted 4,113 Class A Common Shares on 09/30/2025 as compensation for board service.

At what price were the shares reported on the Form 4 for GBLI?

$28.87 per share is the price shown on the Form 4.

How many GBLI shares did the reporting person own after the reported transaction?

The Form 4 reports beneficial ownership of 74,542 Class A Common Shares following the grant.

Was the Form 4 signed and when was it filed?

The filing shows a signature by an attorney-in-fact on 10/02/2025; the transaction date is 09/30/2025.

Does the Form 4 report any derivative transactions for GBLI?

No. Table II contains no reported derivative securities; only the non-derivative grant is reported.